Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.
about
PharmGKB summary: peginterferon-α pathway.The role of pharmacogenetics in the treatment of chronic hepatitis C infection.Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening.Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy.Pharmacogenetics of ribavirin-induced anemia in HCV patients.Inosine triphosphate pyrophosphohydrolase activity: more accurate predictor for ribavirin-induced anemia in hepatitis C infected patients than ITPA genotype.Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV.Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens.
P2860
Q36590755-C5503011-C7BB-4F24-882B-20047039FA1AQ38151586-89A85A7C-2D7F-4AEF-B083-0B9F5173A2FEQ39420843-BA0DC960-9684-4391-BDA8-EA856BB4C082Q40155391-3D3F4A46-2DCA-4900-8E3A-FA8209FDD9BFQ40650428-DEE388B3-1636-4F2E-8C28-6EBE416B65E1Q41236221-99DF3D22-CBFD-44FA-99CD-68959A3ACE80Q42252312-5B158B39-4879-4FB8-BF92-A5AE943EB3D7Q47554338-C8132331-F644-4A2F-8D54-7EE4699CFDF2Q55427239-E6D73112-2DC0-4949-B7FB-00E1A6077DF1
P2860
Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Single and combined IL28B, ITP ...... e to anti-hepatitis C therapy.
@en
Single and combined IL28B, ITP ...... e to anti-hepatitis C therapy.
@nl
type
label
Single and combined IL28B, ITP ...... e to anti-hepatitis C therapy.
@en
Single and combined IL28B, ITP ...... e to anti-hepatitis C therapy.
@nl
prefLabel
Single and combined IL28B, ITP ...... e to anti-hepatitis C therapy.
@en
Single and combined IL28B, ITP ...... e to anti-hepatitis C therapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Single and combined IL28B, ITP ...... e to anti-hepatitis C therapy.
@en
P2093
Alexandra Doehring
Christina Schlecker
Gerd Geisslinger
Wolf Peter Hofmann
P2860
P304
P356
10.2217/PGS.11.99
P577
2011-12-01T00:00:00Z